EMP3 and glioblastoma: Meanwhile, in GBM patients, the survival time and disease-free survival time of GBM patients with low EMP3 expression levels were not significantly different from those of GBM patients with high EMP3 expression levels, and no statistical significance was found after the t-test (Figure 2c,d).